Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 6
Primary Industries
- Drugs
- Personal Care Products
- Pharmaceuticals
- Therapeutic
- Supply
- Skin care
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 1884
License Grant
The Company entered into a Metabolic Moisturizer OTC License Agreement and the Azelaic Acid Agreement dated April 16, 1992 which granted to an exclusive, worldwide royalty-bearing license relates to the Company’s barrier repair technology.
License Property
Glylorin is a consumer products based on another premise underlying its core technology, that repairing the skin barrier may improve the skin’s ability to protect against environmental and occupational insults and thus may help prevent skin diseases and help alleviate conditions such as photoaging and wrinkling.
IPSCIO Record ID: 1723
License Grant
The Company entered into a license agreement with the University providing for an exclusive, world-wide, royalty bearing license, subject to customary government rights, for two use patents for Barrier Repair Formulations; technology, that repairing the skin barrier may improve the skin’s ability to protect against environmental and occupational insults and thus may help prevent skin diseases and help alleviate conditions such as photoaging and wrinkling.
Field of Use
The rights granted apply to the skin.
IPSCIO Record ID: 27978
License Grant
The University grants to Licensee a world-wide license under the University's Patent Rights to make, have made, use, sell, offer to sell and import Licensed Product and to practice Licensed Method to the extent permitted by law. The University also grants to Licensee the right to issue sublicenses to third parties to make, have made, use, sell, offer to sell and import Licensed Product and to practice Licensed Method in the Field of Use as long as Licensee has current exclusive rights thereto under this Agreement.
License Property
Certain inventions, generally characterized as “Lipids for Epidermal Moisturization and Repair of Barrier Functionâ€.
The Licensor for barrier repair technology is a technology that is a specific combination of ceramides, cholesterol and fatty acids which are able to create a human-like skin barrier and thus provide patients with a more normal skin barrier function.
The Barrier Repair platform represents near term revenue opportunities for prescription skin care products to treat a variety of skin disorders all characterized by a disrupted skin barrier. In April 2006, the licensor received clearance from the United States Food and Drug Administration (FDA) to market EpiCeram® their first commercial product using the Barrier Repair technology. EpiCeram® is a prescription-only topical cream intended to treat dry skin conditions and to manage and relieve the burning and itching associated with various types of dermatoses including atopic dermatitis (eczema), irritant contact dermatitis, and radiation dermatitis.
Field of Use
Field of Use means therapeutic and cosmetic applications in mammals, including humans.
IPSCIO Record ID: 6219
License Grant
Licensor hereby grants to Licensee worldwide sublicense under the Licensed Patents to make, have made, use, import, offer to sell, sell and have sold Licensed Products and the Licensed Method in the Licensed Field.
The Licensee has the right to use the Barrier Repair technology (skin care products to treat a variety of skin disorders all characterized by a disrupted skin barrier) to develop and market cosmetic, non-prescription products.
License Property
“Barrier Repair Technology†means the specific combination of ceramides, cholesterol and fatty acids which are able to create a human-like skin barrier embodied in the Licensed Patent.
“Licensed Patent†means U.S. Patent No. 5,643,899, all reissues.
“Triceram™†means a ceramide dominated formulation of the Licensed Product.
Field of Use
“Licensed Field†means cosmetic, non-prescription uses of the Barrier Repair Technology.
IPSCIO Record ID: 28476
License Grant
The Company and the University entered into an agreement whereby University gave the Company worldwide exclusive rights including sub-license rights to the use of its patents and patent applications of the uses of MMP inhibitors.
License Property
MMPs are enzymes that break down extracellular matrix proteins, performing many diverse functions. Their role in skin ageing is due to the fact that they degrade both collagen and elastin, leading to a loss of elasticity and firmness of human skin. MMP inhibitors have, therefore, the potential to protect against wrinkles and fine lines as well as photoageing and a number of anti-ageing products now contain such ingredients.
Field of Use
The rights granted apply to the field of use relating to human skin care.
IPSCIO Record ID: 280833
License Grant
For good and valuable consideration, the adequacy of which is hereby acknowledged, the parties, intending to be legally bound, hereby agree to amend certain sections of the original agreement. Royalty payments in consideration for the license granted has been amended.
License Property
The amended sections include but not limited to
Channel of Trade with respect to products containing glycolic acid shall mean the mail order, multi level, and direct door-to-door markets and to products containing gluconolactone shall mean any market or channel of distribution.
Licensed Products shall include any cosmetic and/or dermatologic preparation covered by the Licensed Patent Rights (a) containing glycolic acid and/or its salts (1) for the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; or (b) cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; or (c) cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin; or (d) cosmetic and dermatological preparations containing gluconolactone for alleviating or improving the signs of dermatological aging of the human skin, including the reduction of human skin wrinkles.
Licensed Patent Rights shall mean, subject to the specific exclusions set forth (as amended herein), and all divisions, continuations, continuations-in-part, reissues, reexaminations and extensions thereof (a) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts for (1) the treatment of human skin wrinkles and/or fine lines on the human skin; (2) the treatment of dry skin; (3) as a skin cleanser; (4) as a hair conditioner; (5) as a shampoo; (b) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts, in combination with salicylic acid for the treatment of acne; (c) covering only cosmetic and dermatologic preparations containing glycolic acid and/or its salts in combination with two percent (2%) or less of hydroquinone for the treatment of pigmented spots on human skin; and (d) covering only cosmetic and dermatological preparations containing gluconolactone for alleviating or improving the signs of dermatological aging of the human skin, including the reduction of human skin wrinkles.
Field of Use
This agreement pertains to skin care.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
